Rudy Li
Stock Analyst at Chardan Capital
(n/a)
# 4,350
Out of 4,714 analysts
5
Total ratings
n/a
Success rate
-21.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRTA Prothena Corporation | Initiates: Buy | $40 | $13.87 | +188.39% | 2 | Dec 20, 2024 | |
| STOK Stoke Therapeutics | Initiates: Buy | $24 | $11.49 | +108.88% | 1 | Dec 20, 2024 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $20 | $7.18 | +178.55% | 2 | Dec 20, 2024 |
Prothena Corporation
Dec 20, 2024
Initiates: Buy
Price Target: $40
Current: $13.87
Upside: +188.39%
Stoke Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $24
Current: $11.49
Upside: +108.88%
Mind Medicine (MindMed)
Dec 20, 2024
Initiates: Buy
Price Target: $20
Current: $7.18
Upside: +178.55%